Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 10:46 PM
Ignite Modification Date: 2025-12-25 @ 8:16 PM
NCT ID: NCT00988169
Description: None
Frequency Threshold: 5
Time Frame: None
Study: NCT00988169
Study Brief: Erlotinib and AT-101 in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Oral Erlotinib and Pulsed Doses of Oral AT-101 Treatment-naïve advanced (Wet Stage IIIB and IV)NSCLC patients with EGFR activating mutations. None None 1 5 5 5 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Hypotension SYSTEMATIC_ASSESSMENT Cardiac disorders CTC-3.0 View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
ALT, SGPT SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTC-3.0 View
AST, SGOT SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTC-3.0 View
Diarrhea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders CTC-3.0 View
Fatigue (asthenia, lethargy, malaise) SYSTEMATIC_ASSESSMENT General disorders CTC-3.0 View
Nausea SYSTEMATIC_ASSESSMENT General disorders CTC-3.0 View
Neutrophils/granulocytes SYSTEMATIC_ASSESSMENT Blood and lymphatic system disorders CTC-3.0 View